This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Goldstein A.Chief U.S. drug regulator backs off-label prescribing. Internet Document: [3 pages], 6 Mar 2007. Available from: URL: http://www.bloomberg.com
About this article
Cite this article
According to the chief US drug regulator, Andrew von Eschenbach, the US government should not interfere. Pharmacoecon. Outcomes News 525, 2 (2007). https://doi.org/10.2165/00151234-200705250-00002
- Public Health
- Health Outcome
- Health Economic
- Drug Company